In 2024, the rating of brokerage investment banking business is nearing the end, and the results of 96 brokers will be released. The reporter was informed that the quality evaluation of brokerage investment banking business in 2024 is nearing the end, and the evaluation scores of investment banking business quality of 96 participating brokers in 2024 have been distributed to companies. After the brokers confirm, the association will start the formal scoring work. In September this year, the China Securities Association launched the quality evaluation of brokerage investment banking business in 2024, and initially determined the participating brokerage and investment banking projects. According to the preliminary statistics, about 68 brokers are expected to get extra points for supporting high-level science and technology in investment banking. (Cailian)Xinshida Inverter has successfully obtained the type approval certificate of China Classification Society. Recently, Xinshida Inverter AS710M has successfully obtained the type approval certificate issued by China Classification Society (CCS), which indicates that Xinshida Electric's products meet the strict standards of the international shipping industry, and also indicates that the company will further expand its market share in the field of ship and ocean engineering.President of Japan Life Insurance: I don't think we are behind our competitors in overseas acquisitions, but we are concerned about different countries.
Spot silver fell 1% in the day and is now reported at $31.57 per ounce.The "moderately loose" monetary policy boosted the confidence of all parties. A50ETF Huabao (159596) attracted 17.02 million yuan of gold yesterday. On December 11, the Shanghai Composite Index fluctuated within a narrow range in the morning, and A50ETF Huabao (159596) fell slightly by 0.18% with a turnover of 84.21 million yuan. In terms of constituent stocks, the top ten awkward stocks are mixed. On the upside, Midea Group led the gains, followed by Zijin Mining and Changjiang Power. On the downside, Hengrui Pharma led the decline. In terms of capital flow, A50ETF Huabao (159596) received a net inflow of 17.02 million yuan yesterday. China Post Securities said that the the Political Bureau of the Communist Party of China (CPC) Central Committee meeting continued to actively set the tone, and the policy turned loose, and expanding domestic demand in all directions became the current policy direction. This meeting made it clear that "strengthening unconventional countercyclical adjustment" and the fiscal policy adjustment was "more active", which basically met market expectations; The monetary policy is set to be "moderately loose", and the tone is adjusted again after 14 years. Next year, it is expected to be wide in currency and credit.According to the survey of Monetary Authority of Singapore, 33% people expect that the slope of Singapore's exchange rate will be lowered in the January monetary policy evaluation (previously 50%).
Before the Bank of Japan's policy meeting, it released chaotic signals. Japanese traders were confused about when to raise interest rates. After the Bank of Japan officials' remarks and media reports sent different signals, traders have been confused about when the central bank might raise interest rates in the past week. This kind of confusion led to sharp fluctuations in the market's interest rate hike bets. The overnight index swap pricing showed that the probability of raising interest rates in December was 22%, which was significantly lower than 60% at the beginning of last week. This week, the yen fell from 150 last Friday to a low of 152.18 to the dollar, and the exchange rate was 151.73 at 10:40 Tokyo time. Kazuo Ueda, governor of the Bank of Japan, said in an interview last month that the interest rate hike was approaching. A few days later, a report by the news agency emphasized the concern of the central bank about raising interest rates prematurely. Tomaki Nakamura, a member of the Dove Policy Committee, said last week that he was not opposed to raising interest rates, but this month's policy decision must consider data factors.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.Tang Daizhi, the former deputy chief economist of China Offshore Oil Group Co., Ltd., was investigated. According to the news from the Discipline Inspection and Supervision Team of China Offshore Oil Group Co., Ltd. and the Supervision Committee of Jiangsu Provincial Commission for Discipline Inspection, Tang Daizhi, the former deputy chief economist of China Offshore Oil Group Co., Ltd., the general manager of human resources department and the head of party organization department, is suspected of serious violation of discipline and law, and is currently under disciplinary review and supervision investigation by the Discipline Inspection and Supervision Team of China Offshore Oil Group Co., Ltd. and the Jiangsu Provincial Supervision Committee.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide 12-14